Showing results (151-160 of 481) with videos related to

Sort By:
Pageof 49
Clinical Laboratory|January 16, 2026
Clinical and Laboratory Characteristics of ABO-Incompatible Hemolytic Disease of the Fetus and NewbornHan Joo Kim, Kiwook Jung, Jin Seok Kim, et al.
Journal of Korean Medical Science|October 12, 2019
The First Case of Para-Bombay Blood Type Encountered in a Korean Tertiary HospitalMin Sun Kim, Jin Seok Kim, Hyewon Park, et al.
Hematological Oncology|July 22, 2016
Clinical impact of early recovery of peripheral blood absolute lymphocyte count after frontline autologous stem cell transplantation for diffuse large B-cell lymphomaYundeok Kim, Soo-Jeong Kim, June-Won Cheong, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 21, 2019
Fatal hemolytic disease of the fetus and newborn caused by anti-Jra antibody: A case report and literature reviewMin-Sun Kim, Jin Seok Kim, Hyewon Park, et al.
Radiation Oncology Journal|February 7, 2014
Patterns of care and treatment outcomes for primary thyroid lymphoma: a single institution studyHyejung Cha, Jun Won Kim, Chang-Ok Suh, et al.
Microbiology (Reading, England)|January 5, 2008
N-terminal residues of SipB are required for its surface localization on Salmonella enterica serovar TyphimuriumHyeon Guk Kim, Bae Hoon Kim, Jin Seok Kim, et al.
Annals of Hematology|August 20, 2014
Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemiaJi Eun Jang, Soo Jeong Kim, June-Won Cheong, et al.
Pediatric Pulmonology|July 22, 2010
Clinical characteristics of Korean pediatric patients critically ill with influenza A (H1N1) virusSoo Youn Shin, Joon Hyung Kim, Hyun Su Kim, et al.
Pharmaceutics|January 21, 2023
Evaluation of pH-Sensitive Polymeric Micelles Using Citraconic Amide Bonds for the Co-Delivery of Paclitaxel, Etoposide, and RapamycinMin Jeong Jo, Hee Ji Shin, Moon Sup Yoon, et al.
British Journal of Haematology|August 30, 2002
Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotypeSeung Tae Lee, Joon Ho Jang, June-Won Cheong, et al.
Pageof 49